Optimizing fluoroquinolone utilization in a public hospital: a prospective study of educational intervention

被引:16
作者
Lacombe, K
Cariou, S
Tilleul, P
Offenstadt, G
Meynard, JL
机构
[1] St Antoine Hosp APHP, Infect & Trop Dis Dept, F-75012 Paris, France
[2] St Antoine Hosp APHP, Dept Pharm, F-75012 Paris, France
[3] St Antoine Hosp APHP, Intens Care Unit, F-75012 Paris, France
关键词
D O I
10.1007/s10096-004-1246-x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Fluoroquinolone (FQ) utilization should be optimized, with the aim of controlling both multidrug-resistant bacteria and costs. In the present study, the appropriateness of FQ prescriptions for urinary tract infections (UTIs) before and after an educational intervention was examined prospectively. FQ-prescribing physicians received oral and written guidelines between the two phases of the study. All patients admitted to Saint-Antoine University Hospital (Paris) and treated with FQs for UTIs during the study period were included. The main outcome measures of the appropriateness of FQ prescriptions were based on the principles of Antibiotic Utilization Review. The study involved 127 patients. The main prescribing errors before the intervention were wrong routes of administration and failure to take into account antibiotic susceptibility results. The rate of erroneous prescriptions fell by 74.4% after intervention. About 71% of the improvement can be attributed to the intervention (71.4%; 95% confidence interval, 39.3-86.8). The intervention had an overall positive impact on FQ prescription quality. The decrease in inappropriate prescriptions was due mainly to the use of antibiotic susceptibility results (23% vs. 11.5%, P<0.05) and better consideration of indications (18.9% vs. 3.8%; P<0.05). Future educational interventions will cover other indications and will take into account costs and local antimicrobial susceptibility patterns.
引用
收藏
页码:6 / 11
页数:6
相关论文
共 25 条
[1]   Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pneumonia [J].
Clark, LC ;
Davis, CW .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (22) :S10-S13
[2]  
Edwards AL., 1985, MULTIPLE REGRESSION
[3]   Effectiveness of addiction science presentations to treatment professionals, using a modified Solomon study design [J].
Erickson, CK ;
Wilcox, RE ;
Miller, GW ;
Littlefield, JH ;
Lawson, KA .
JOURNAL OF DRUG EDUCATION, 2003, 33 (02) :197-216
[4]   THE DEFINITION OF DRUG UTILIZATION REVIEW - STATEMENT OF ISSUES [J].
ERWIN, WG .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 50 (05) :596-599
[5]   Emergence and dissemination of quinolone-resistant Escherichia coli in the community [J].
Garau, J ;
Xercavins, M ;
Rodríguez-Carballeira, M ;
Gómez-Vera, JR ;
Coll, I ;
Vidal, D ;
Llovet, T ;
Ruíz-Bremón, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) :2736-2741
[6]   Use of a physician order entry system to identify opportunities for intravenous to oral levofloxacin conversion [J].
Glemaud, I .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (22) :S14-S16
[7]  
Goldstein F W, 1995, Drugs, V49 Suppl 2, P36
[8]  
Grimshaw J, 1995, Qual Health Care, V4, P55, DOI 10.1136/qshc.4.1.55
[9]   EFFECT OF CLINICAL GUIDELINES ON MEDICAL-PRACTICE - A SYSTEMATIC REVIEW OF RIGOROUS EVALUATIONS [J].
GRIMSHAW, JM ;
RUSSELL, IT .
LANCET, 1993, 342 (8883) :1317-1322
[10]   Community-acquired lower respiratory tract infections - Etiology and treatment [J].
Guthrie, R .
CHEST, 2001, 120 (06) :2021-2034